Weighted Average Number of Shares Outstanding, Basic of Niagen Bioscience, Inc. from 02 Jul 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Niagen Bioscience, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 02 Jul 2011 to 31 Dec 2025.
  • Niagen Bioscience, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2025 was 79,178,000, a 4.3% increase year-over-year.
  • Niagen Bioscience, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2025 was 79,178,000, a 4.3% increase from 2024.
  • Niagen Bioscience, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 75,929,000, a 1.3% increase from 2023.
  • Niagen Bioscience, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 74,985,000, a 7.5% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Niagen Bioscience, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 79,178,000 +3,249,000 +4.3% 01 Oct 2025 31 Dec 2025 10-K 04 Mar 2026 2025 FY
Q3 2025 79,779,000 +3,807,000 +5% 01 Jul 2025 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 79,249,000 +3,690,000 +4.9% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 77,810,000 +2,580,000 +3.4% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 75,929,000 +944,000 +1.3% 01 Oct 2024 31 Dec 2024 10-K 04 Mar 2026 2025 FY
Q3 2024 75,972,000 +922,000 +1.2% 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2025 2025 Q3
Q2 2024 75,559,000 +592,000 +0.79% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025 2025 Q2
Q1 2024 75,230,000 +434,000 +0.58% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025 2025 Q1
Q4 2023 74,985,000 +5,256,000 +7.5% 01 Oct 2023 31 Dec 2023 10-K 04 Mar 2025 2024 FY
Q3 2023 75,050,000 +6,705,000 +9.8% 01 Jul 2023 30 Sep 2023 10-Q 31 Oct 2024 2024 Q3
Q2 2023 74,967,000 +6,631,000 +9.7% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2024 Q2
Q1 2023 74,796,000 +6,482,000 +9.5% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q4 2022 69,729,000 +2,544,000 +3.8% 01 Oct 2022 31 Dec 2022 10-K 06 Mar 2024 2023 FY
Q3 2022 68,345,000 +109,000 +0.16% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023 2023 Q3
Q2 2022 68,336,000 +350,000 +0.52% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023 2023 Q2
Q1 2022 68,314,000 +4,150,000 +6.5% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q4 2021 67,185,000 01 Oct 2021 31 Dec 2021 10-K 08 Mar 2023 2022 FY
Q3 2021 68,236,000 +6,541,000 +11% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022 2022 Q3
Q2 2021 67,986,000 +7,080,000 +12% 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022 2022 Q2
Q1 2021 64,164,000 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q3 2020 61,695,000 01 Jul 2020 30 Sep 2020 10-Q 03 Nov 2021 2021 Q3
Q2 2020 60,906,000 01 Apr 2020 30 Jun 2020 10-Q 03 Aug 2021 2021 Q2
Q3 2018 55,068* +8,003 01 Jul 2018 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q4 2017 51,178,664 +13,274,130 +35% 01 Oct 2017 30 Dec 2017 10-K 15 Mar 2018 2017 FY
Q3 2017 47,065* -37,821,607 02 Jul 2017 30 Sep 2017 10-Q 07 Nov 2018 2018 Q3
Q2 2017 42,121,150 +5,131,118 +14% 02 Apr 2017 01 Jul 2017 10-K 15 Mar 2018 2017 FY
Q1 2017 38,030,688 +1,616,647 +4.4% 01 Jan 2017 01 Apr 2017 10-K 15 Mar 2018 2017 FY
Q4 2016 37,904,534 +2,027,193 +5.6% 02 Oct 2016 31 Dec 2016 10-K 15 Mar 2018 2017 FY
Q3 2016 37,868,672 -69,574,244 -65% 03 Jul 2016 01 Oct 2016 10-K 15 Mar 2018 2017 FY
Q2 2016 36,990,032 +1,186,734 +3.3% 03 Apr 2016 02 Jul 2016 10-K 15 Mar 2018 2017 FY
Q1 2016 36,414,041 +681,175 +1.9% 03 Jan 2016 02 Apr 2016 10-K 15 Mar 2018 2017 FY
Q4 2015 35,877,341 +390,881 +1.1% 04 Oct 2015 02 Jan 2016 10-K 16 Mar 2017 2016 FY
Q3 2015 107,442,916 +832,516 +0.78% 05 Jul 2015 03 Oct 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 35,803,298 -70,382,286 -66% 05 Apr 2015 04 Jul 2015 10-Q 11 Aug 2016 2016 Q2
Q1 2015 35,732,866 -70,343,495 -66% 03 Jan 2015 04 Apr 2015 10-Q 12 May 2016 2016 Q1
Q4 2014 35,486,460 -64,500,983 -65% 28 Sep 2014 03 Jan 2015 10-K 16 Mar 2017 2016 FY
Q3 2014 106,610,400 +5,300,461 +5.2% 29 Jun 2014 27 Sep 2014 10-Q 12 Nov 2015 2015 Q3
Q2 2014 106,185,584 +6,351,621 +6.4% 30 Mar 2014 28 Jun 2014 10-Q 13 Aug 2015 2015 Q2
Q1 2014 106,076,361 +11,450,241 +12% 29 Dec 2013 29 Mar 2014 10-Q 14 May 2015 2015 Q1
Q4 2013 99,987,443 +9,718,641 +11% 29 Sep 2013 28 Dec 2013 10-K 17 Mar 2016 2015 FY
Q3 2013 101,309,939 +8,945,521 +9.7% 30 Jun 2013 28 Sep 2013 10-Q 06 Nov 2014 2014 Q3
Q2 2013 99,833,963 +8,471,299 +9.3% 31 Mar 2013 29 Jun 2013 10-Q 12 Aug 2014 2014 Q2
Q1 2013 94,626,120 +9,919,924 +12% 30 Dec 2012 30 Mar 2013 10-Q 08 May 2014 2014 Q1
Q4 2012 90,268,802 30 Sep 2012 29 Dec 2012 10-K 27 Mar 2014 2013 FY
Q3 2012 92,364,418 +21,738,505 +31% 01 Jul 2012 29 Sep 2012 10-Q 21 Nov 2013 2013 Q3
Q2 2012 91,362,664 +26,360,685 +41% 01 Apr 2012 30 Jun 2012 10-Q/A 05 Dec 2013 2013 Q2
Q1 2012 84,706,196 01 Jan 2012 31 Mar 2012 10-Q/A 05 Dec 2013 2013 Q1
Q3 2011 70,625,913 03 Jul 2011 01 Oct 2011 10-Q 08 Nov 2012 2012 Q3
Q2 2011 65,001,979 03 Apr 2011 02 Jul 2011 10-Q/A 10 Aug 2012 2012 Q2

Niagen Bioscience, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 79,178,000 +3,249,000 +4.3% 01 Jan 2025 31 Dec 2025 10-K 04 Mar 2026 2025 FY
2024 75,929,000 +944,000 +1.3% 01 Jan 2024 31 Dec 2024 10-K 04 Mar 2026 2025 FY
2023 74,985,000 +5,256,000 +7.5% 01 Jan 2023 31 Dec 2023 10-K 04 Mar 2025 2024 FY
2022 69,729,000 +2,544,000 +3.8% 01 Jan 2022 31 Dec 2022 10-K 06 Mar 2024 2023 FY
2021 67,185,000 +6,118,000 +10% 01 Jan 2021 31 Dec 2021 10-K 08 Mar 2023 2022 FY
2020 61,067,000 01 Jan 2020 31 Dec 2020 10-K 14 Mar 2022 2021 FY
2016 37,294,321 +1,416,980 +4% 03 Jan 2016 31 Dec 2016 10-K 16 Mar 2017 2016 FY
2015 35,877,341 +390,881 +1.1% 04 Jan 2015 02 Jan 2016 10-K 16 Mar 2017 2016 FY
2014 35,486,460 -64,500,983 -65% 29 Dec 2013 03 Jan 2015 10-K 16 Mar 2017 2016 FY
2013 99,987,443 +9,718,641 +11% 30 Dec 2012 28 Dec 2013 10-K 17 Mar 2016 2015 FY
2012 90,268,802 +21,961,990 +32% 01 Jan 2012 29 Dec 2012 10-K 27 Mar 2014 2013 FY
2011 68,306,812 02 Jan 2011 31 Dec 2011 10-K 29 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.